Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 04-2004 | 03-2004 | 01-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,240 | N/A | -1,720 | -1,720 | -910 |
| Depreciation Amortization | 140 | N/A | 100 | 100 | 60 |
| Accounts receivable | N/A | -46 | N/A | 0 | N/A |
| Other Working Capital | 230 | N/A | 280 | 280 | 40 |
| Other Operating Activity | 100 | 46 | 90 | 90 | 10 |
| Operating Cash Flow | $-1,770 | $N/A | $-1,250 | $-1,250 | $-800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -80 | N/A | -80 | -80 | -10 |
| Purchase Sale Intangibles | N/A | -25 | N/A | 0 | N/A |
| Other Investing Activity | -20 | 0 | -10 | -10 | -10 |
| Investing Cash Flow | $-100 | $N/A | $-90 | $-90 | $-20 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 2,002 | N/A | 0 | N/A |
| Other Financing Activity | 2,000 | -2,002 | 1,900 | 1,900 | 1,120 |
| Financing Cash Flow | $2,000 | $N/A | $1,900 | $1,900 | $1,120 |
| Beginning Cash Position | 170 | N/A | 170 | 170 | 170 |
| End Cash Position | 300 | N/A | 720 | 720 | 470 |
| Net Cash Flow | $120 | $N/A | $540 | $540 | $290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,770 | N/A | -1,250 | -1,250 | -800 |
| Capital Expenditure | N/A | -80 | N/A | 0 | N/A |
| Free Cash Flow | -1,770 | -80 | -1,250 | -1,250 | -800 |